d6b0ed5e_tus_Filed_Pursuant_to_Rule_424__2
[0] Over-allotment option [2] 
The underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of our common stock to cover over-allotments.
PTC Therapeutics - Prospectus Filed Pursuant to Rule 424
2